Results 261 to 270 of about 88,244 (379)

Preparation of radiolabeled GM2 and GA2 gangliosides.

open access: hybrid, 1979
Amanda J Novak   +3 more
openalex   +1 more source

A Human Mass Balance and Metabolism Study of [14C]‐Ubrogepant in Healthy Male Adults

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.
Abstract Ubrogepant is a calcitonin gene–related peptide receptor antagonist approved for the acute treatment of migraine with or without aura in adults. The mass balance and metabolism of ubrogepant was evaluated in six healthy male adults administered a single oral dose of [14C]‐ubrogepant 50 mg (∼200 µCi).
Ramesh R. Boinpally   +13 more
wiley   +1 more source

68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling

open access: yesJournal of Nuclear Medicine, 2017
Jennifer D. Young   +8 more
semanticscholar   +1 more source

Synthesis and Evaluation of Radioiodinated [125I]7‐Iodo‐5H‐Pyrido[4,3‐B]Indole ([125I]CTAU) in Postmortem Human Alzheimer's Disease Brain

open access: yesJournal of Labelled Compounds and Radiopharmaceuticals, Volume 69, Issue 1, January 2026.
[125I]CTAU, a new analog of [18F]T807, was found to be suitable for imaging tau protein in postmortem human Alzheimer's disease brain slices. [125I]CTAU may be among the smaller ring structures that bind to tau protein. ABSTRACT The aim of this study was to further understand the tau imaging agent, flortaucipir (T807), by making small modifications and
Chloe C. McNamara   +5 more
wiley   +1 more source

Radiolabeling molecular biomarkers of invasive pituitary adenomas: a narrative review. [PDF]

open access: yesPituitary
Marche C   +6 more
europepmc   +1 more source

Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer

open access: green, 2020
Kim H. Kwan   +12 more
openalex   +2 more sources

In Vitro Evaluation of Hemiarthroplasty Bearing Materials: A Scoping Review (Part I)

open access: yesJournal of Orthopaedic Research, Volume 44, Issue 1, January 2026.
ABSTRACT Hemiarthroplasty is used to treat joint damage confined to one side, aiming to preserve the remaining healthy cartilage and bone while addressing conditions like femur fractures and osteonecrosis; however, challenges persist due to cartilage wear and inconsistent clinical outcomes.
Victoria P. Marino   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy